Company / Free Cash Flow
ARDELYX, INC. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$44.0M
FY2025
5-year range
-$154.4M / -$44.0M
FY2021-FY2025
Trend
+4.0%
vs FY2024
Sector context
#78 of 194
Health Care
What the data says
At -$44M, ARDELYX, INC.'s free cash flow ranks #78 of 194 in the Health Care sector. Free Cash Flow has fluctuated over the past 10 years, ranging from -$154M in FY2021 to $12M in FY2016.
Based on SEC 10-K filings.
-$44M in FY2025.
Improved from -$90M to -$44M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#78 of 194 in Health CareTop 40% of 194This company -$44.0M Sector average $470.6M
▼
-109.3% below sector average
Key checks
Key Insights
- In FY2025, free cash flow increased 4.0% year-over-year.
- Ranks #78 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2016.
- Lowest free cash flow in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$44.0M | +4.0% |
| FY2024 | -$45.8M | +49.1% |
| FY2023 | -$90.1M | -28.5% |
| FY2022 | -$70.1M | +54.6% |
| FY2021 | -$154.4M | -88.9% |
| FY2020 | -$81.8M | -6.4% |
| FY2019 | -$76.8M | -8.8% |
| FY2018 | -$70.6M | +6.3% |
| FY2017 | -$75.3M | -752.4% |
| FY2016 | $11.5M | +115.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026